69th Canadian Rheumatology
Association Annual Scientific Meeting
Professions Association Annual Scientific Meeting
February 26- March 1, 2014, Whistler, BC
THE ABSTRACT SUBMISSION SITE IS NOW CLOSED.
Call for Abstracts
Attendees at the 2014 Canadian Rheumatology Association Annual Scientific
Meeting and the Arthritis Health Professions Association Annual Scientific Meeting
are invited to submit abstracts for presentation during the meeting. We
encourage you to submit abstracts relating to original research, systematic
reviews or meta-analyses. Case reports or case series are acceptable. Project
proposals without data or results will not be accepted. Although research presented
at another meeting can be submitted, priority will be given to research which
has not been previously presented.
The purpose of this meeting is to showcase the various research endeavours
of the Canadian Rheumatology Association (CRA) and the Arthritis Health Professions
Association (AHPA) members as well as to foster research collaboration and exchange
- During the on-line submission process, you will be asked to enter the first
author, the first author’s contact information, and the names and e-mail addresses
of all co-authors (as well as the email of an optional additional correspondent,
- Please ensure the e-mail address of the first author is accurate, as this
will be the sole method of communication regarding acceptance. If necessary,
change of email address must be sent to Virginia@rheum.ca.
- There is a limit of 400 words for each abstract. This does not include abstract
title and author names. Longer submissions will be cut off at the word limit.
- All submissions must be input (typed or copied) into the correct field.
There is no uploading of abstract files.
- No tables or graphs will be accepted.
- Each page of the submission process is automatically saved.
- You will receive an e-mail confirmation for each submission.
- In order to successfully receive emails regarding your abstract submission,
you must add ‘@owpm.com’ as a safe sender in your mail client. Click
here for help adding safe senders.
- There are 2 categories of submissions: investigator-initiated abstracts
and industry-initiated abstracts.
- You may work on your abstract until the abstract submission deadline (October
- Deadline for submission is October 21st, 23:59 PDT. Abstracts submitted
after the deadline will not be accepted.
- Your abstract submission will not be complete, nor will the abstract be
reviewed until payment is made. Deadline for payment is October 21st. Online
payment is available during the submission process. The following non-refundable
fees will be charged: $30.00 (plus HST) for investor-initiated abstracts and
$100.00 (plus HST) for industry-initiated abstracts.
- Only online abstract submissions will be accepted.
- An author submitting an abstract or case report MUST be prepared to present
their work at the meeting in person or to send a co-author to do so otherwise
the poster will not be presented and the abstract will not be published in
the Journal of Rheumatology. There will be two poster sessions at the 2014
meeting, date and time TBD. Please ensure you make your travel arrangements
to be able to attend the poster session to which you have been assigned.
- An acceptance/rejection email will be sent out on or about December
- By submitting an abstract for consideration, all authors agree to abide
by the rules outlined above, and the conditions, deadlines, policies and decisions
of the CRA organizing committee.
- Abstracts will be blindly reviewed & graded by members of the CRA Abstract
- The CRA Abstract Review Committee will choose outstanding abstracts suitable
for oral presentation.
- Trainee abstracts will be chosen for oral presentations (date TBD) as part
of the scientific meeting and will enter a competition for trainee research
awards. Trainees include medical students, residents, rheumatology fellows
and post-graduate students. Individuals holding a Faculty appointment do not
qualify as trainees. When submitting an abstract for oral presentation, trainees
must choose one of three categories: Basic Science, Clinical, or topics related
- Oral presentations of original investigator-initiated research will be selected
from abstracts to be presented during a plenary session (date TBD).
These awards have been established to recognize exceptional research presented
as an Abstract and to encourage participation of young faculty and trainees
at the CRA Annual Scientific Meeting. The first author must be identified as
a Young Faculty or Trainee during the application process.
- The abstracts for both Oral and Poster presentations will be published in
the Journal of Rheumatology following their rules regarding publication rights.
Submitting an abstract to the CRA meeting obliges the submitter to allow the
abstract to be printed according to the rules of the Journal of Rheumatology.
- All abstracts will be available online for downloading prior to the meeting.
- All abstracts must be presented in the following format: 1. Objective(s);
2. Method(s); 3. Result(s); 4. Conclusion(s). Do not include educational qualifications,
industry support, introductions, historical data, or literature reviews/bibliographies
in the text of the abstract.
- Disclosures and conflicts of interest must be reported in the appropriate
- All presentations (oral and posters) must be presented in English.
- Poster size will be indicated in the acceptance notification.
- QR Codes will be allowed on posters. The QR code should allow participants
to view the poster online without any form of advertising or promotional material.
- All Abstracts must be submitted in English.
Disclosures and conflict of interest
A conflict of interest may exist if an author or co-author has a financial
interest in, or is otherwise affiliated with, a commercial organization that
may have a direct or indirect interest in the content of his/her submission.
CRA requires that all authors disclose such pertinent relationships and inform
participants of these relationships at the time of submission. The presence
of a potential conflict of interest does not preclude participation in the submission
or presentation process but declaration informs participants of the affiliation
so that they may be aware of possible bias in the content.
A “financial interest” may include but is not limited to:
- being a shareholder
- receiving research funding or other support
- receiving fees or other benefits for any role (including speaking at CPD
- being a paid employee or consultant
An “affiliation” may include but is not limited to:
- holding a position in the organization
- sitting on an advisory committee
- playing some other role of benefit to the organization
|October 21, 2013
||Abstract submission deadline.
|December 31, 2013
||Email notification of acceptance or rejection
for all abstracts.
|January 10, 2014
||Poster session presenters (author or co-author)
must confirm attendance at poster session.
Submitters can choose up to three of the following topics for their abstract:
- Ankylosing Spondylitis
- Anti-Phosholipid Syndrome
- Auto-Immune Diseases
- Basic Science
- Chronic Pain
- Clinical Research
- Gout or Crystalline Arthritis
- Health Economics
- Health Services Research
- Imaging of Rheumatic Disease
- Infectious Arthritis
- Juvenile Idiopathic Arthritis
- Musculoskeletal Examination
- Pediatric Rheumatology
- Psoriatic Arthritis
- Public Health and Arthritis
- Reactive Arthritis
- Regional Pain Syndrome
- Rheumatoid Arthritis
- Sjogren’s Syndrome
- SLE / Anti-Phosholipid Syndrome
- Systemic Sclerosis
- Miscellaneous / Other
For questions about the CRA abstract & case guidelines and process, please
Canadian Rheumatology Association